Jaguar Health (JAGX) Assets (2014 - 2026)
Jaguar Health (JAGX) posted quarterly Assets of $37.4 million for Q1 2026, down 27.26% year-over-year from $51.5 million in Q1 2025, and up 835.85% quarter-over-quarter from $4.0 million in Q4 2025.
Jaguar Health (JAGX) Assets (2014 - 2026) Analysis & Trends
Jaguar Health (JAGX) has reported Assets for 13 consecutive years, with $37.4 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Assets fell 27.26% year-over-year to $37.4 million; the TTM figure through Mar 2026 stood at $37.4 million (down 27.26% YoY), while the FY2025 annual figure was $4.0 million, down 92.51% from the prior year.
- Assets rose to $37.4 million in Q1 2026 per JAGX's latest filing, from $4.0 million in the prior quarter.
- Across five years, Assets topped out at $61.5 million in Q2 2024 and bottomed at $4.0 million in Q4 2025.
- Historically, Assets has averaged $48.6 million across 5 years, with a median of $51.3 million in 2022.
- Annual changes were most pronounced in 2024 — Assets increased 28.84% — and 2025, when it tumbled 92.51%.
- Jaguar Health's Assets stood at $47.5 million in 2022, then grew by 6.98% to $50.8 million in 2023, then gained by 5.24% to $53.4 million in 2024, then sank by 92.51% to $4.0 million in 2025, then soared by 835.85% to $37.4 million in 2026.
- Business Quant data shows JAGX's Assets at $37.4 million in Q1 2026, $4.0 million in Q4 2025, and $49.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.41 Bn | 130.56 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 86.12 Bn | 78.12 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 64.41 Bn | 59.23 Bn | 1.37 Bn | 10.03 Bn |
| 4 | Moderna | 57.56 Bn | 52.43 Bn | 52.00 Mn | 10.96 Bn |
| 5 | BeOne Medicines | 42.06 Bn | 36.96 Bn | 1.53 Bn | 9.18 Bn |
| 6 | Alnylam Pharmaceuticals | 30.95 Bn | 27.65 Bn | 992.69 Mn | 5.56 Bn |
| 7 | BioNTech SE | 27.48 Bn | 9.09 Bn | 668.28 Mn | 25.60 Bn |
| 8 | Insmed | 27.31 Bn | 26.15 Bn | 358.27 Mn | 2.10 Bn |
| 9 | Royalty Pharma | 27.04 Bn | 26.20 Bn | - | 19.82 Bn |
| 10 | Jaguar Health | 459,051.31 | -9.60 Mn | 19.11 Mn | 37.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 37.43 Mn |
| Dec 31, 2025 | 4.00 Mn |
| Sep 30, 2025 | 49.47 Mn |
| Jun 30, 2025 | 48.27 Mn |
| Mar 31, 2025 | 51.46 Mn |
| Dec 31, 2024 | 53.43 Mn |
| Sep 30, 2024 | 58.47 Mn |
| Jun 30, 2024 | 61.46 Mn |
| Mar 31, 2024 | 55.39 Mn |
| Dec 31, 2023 | 50.76 Mn |
| Sep 30, 2023 | 45.38 Mn |
| Jun 30, 2023 | 52.17 Mn |
| Mar 31, 2023 | 56.93 Mn |
| Dec 31, 2022 | 47.45 Mn |
| Sep 30, 2022 | 51.29 Mn |
| Jun 30, 2022 | 49.89 Mn |
| Mar 31, 2022 | 52.91 Mn |
| Dec 31, 2021 | 53.27 Mn |
| Sep 30, 2021 | 59.26 Mn |
| Jun 30, 2021 | 69.54 Mn |